Catalysts for LP Pharmaceutical (Xiamen) Co Ltd
33 tracked
Mar 18, 2026
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Mar 6, 2026
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 23, 2026
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 23, 2026
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 23, 2026
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 23, 2026
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 23, 2026
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 23, 2026
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 23, 2026
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 23, 2026
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Oct 23, 2025
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Oct 23, 2025
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Mar 12, 2025
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Jun 13, 2024
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Mar 28, 2024
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Mar 10, 2023
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Mar 10, 2023
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Dec 2, 2022
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 4, 2022
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 18, 2021
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 14, 2020
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Feb 21, 2019
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
May 21, 2018
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
May 21, 2018
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
May 21, 2018
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Mar 29, 2017
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Mar 29, 2017
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Jun 16, 2015
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Mar 30, 2015
approval
QUDEXY XR (TOPIRAMATE) — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→
Nov 17, 2014
approval
TOPIRAMATE — FDA approval
LP Pharmaceutical (Xiamen) Co Ltd
→